arrow
R

Rosa Collado

hospital general de valencia
H指数:27
被引数:2,313

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of venetoclax‐based therapies on CLL‐associated autoimmune cytopenias: A retrospective study conducted by ERIC

维奈克拉为基础疗法对CLL相关自身免疫性血细胞减少症的影响:ERIC开展的一项回顾性研究

2026-11-060
OAAI
Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications

多发性骨髓瘤的遗传架构:从体细胞变异到生殖系易感性和临床意义

2026-05-010
OAAI
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

鉴定四种自噬相关遗传变异为慢性淋巴细胞白血病的风险因素

2025-09-050
OAAI
Iatrogenic cerebral amyloid angiopathy and Alzheimer's disease co-pathology
2024-12-271
OA
Assessment of the IPSS-M in Chronic Myelomonocytic Leukemia

IPSS-M在慢性髓系单核细胞白血病中的评估

BLOOD
IF23.1
2024-11-050
PRE
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

2024-09-170
OAAI
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

2023-09-2911
OAAI
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病和严重新型冠状病毒肺炎患者的血栓和出血并发症: 欧洲CLL研究计划ERIC的研究

2022-08-268
OAAI
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
2021-03-1115
OAAI
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
2021-01-0612
PREAI
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group

临床试验以外的慢性淋巴细胞白血病奥比妥珠单抗 ± 氯霉素联合一线治疗: ERIC和以色列CLL研究组的多国多中心研究结果

2020-03-1412
OAAI
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
2018-12-0239
OAAI
Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

同染色体17q的慢性淋巴细胞白血病: 与TP53突变和复杂核型相关的侵袭性亚组

2017-11-015
PREAI
Excess mortality in the myelodysplastic syndromes
2016-12-0713
OAAI
Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference
2016-04-2132
OAAI
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes

染色体易位对骨髓增生异常综合征和慢性粒-单核细胞白血病患者预后的影响.西班牙骨髓增生异常综合征组的一项研究

2015-12-229
PREAI
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study
2015-06-0123
PREAI